市场调查报告书
商品编码
1597120
北美血气和电解质分析仪市场预测至 2031 年 - 区域分析 - 按产品和最终用户North America Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User |
2023年北美血气和电解质分析仪市值为9.3697亿美元,预计2031年将达到14.0502亿美元;预计2023年至2031年复合年增长率为5.2%。
医院急诊病患数量的增加推动了北美血气和电解质分析仪市场
糖尿病、癌症、心臟病和其他慢性病盛行率的上升推动了对医院急诊室 (ER) 的需求。医院急诊室为需要立即关注和医疗介入的严重慢性病患者提供重要的医疗照护。这些服务很复杂,每个部分对于提供护理至关重要。紧急医疗服务的主要目标是立即治疗内科、外科和产科问题。在急诊医院急诊室寻求治疗的患者数量不断增加,对血液气体和电解质分析仪的需求产生了积极影响。根据世界卫生组织 (WHO) 统计,全球每年约有 1.5 亿名患者前往医院急诊室就诊。根据 CDC 2023 年发布的资料,美国每年急诊就诊人数约为 1.398 亿人次。碱平衡的及时诊断资讯变得至关重要。血液气体和电解质分析仪提供现场诊断资料,用于评估和管理受呼吸窘迫、代谢异常或重症状况影响的患者。这些分析仪能够即时了解患者的氧合状态、酸碱平衡和电解质水平,对于指导復苏措施和优化紧急情况下的临床结果至关重要。
急诊室对血气和电解质分析仪的需求不断增长,推动了便携式和护理点设备等技术的进步,这些设备可以在患者床边进行快速检测。这些紧凑型分析仪有助于及时诊断和开始治疗,从而提高工作流程效率并改善患者治疗结果。随着医院优先加强紧急护理服务以满足不断增长的患者人数的需求,血气和电解质分析仪市场越来越多地采用针对紧急和重症护理环境量身定制的技术先进的解决方案。
北美血气与电解质分析仪市场概述
北美血气和电解质分析仪市场已细分为美国、加拿大和墨西哥。 2023年,美国在北美血气和电解质分析仪市场中占据最大份额。应用。随着市场上各种主要参与者的出现,北美的血液气体和电解质分析仪测试套件市场预计将受到刺激。此外,在医疗保健运作中采用医疗设备来提高品质和降低成本,也促进了该地区血气和电解质分析仪市场的成长。
北美血气及电解质分析仪市场收入及 2031 年预测(百万美元)
北美血气和电解质分析仪市场细分
北美血气和电解质分析仪市场按产品、最终用户和国家分类。
依产品,北美血气电解质分析仪市场分为血液气体分析仪、电解质分析仪、组合分析仪等。组合分析仪细分市场在 2023 年占据最大的市场份额。
按最终用户划分,北美血气和电解质分析仪市场分为医院和诊所、临床和诊断实验室、家庭护理等。 2023 年,临床和诊断实验室领域占据最大的市场份额。
按国家/地区划分,北美血气和电解质分析仪市场分为美国、加拿大和墨西哥。 2023年,美国主导北美血气和电解质分析仪市场。
Abbott Laboratories、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、Siemens Healthineers AG、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是一些领先的公司在北美血气和电解质分析仪市场运作。
The North America blood gas and electrolyte analyzer market was valued at US$ 936.97 million in 2023 and is projected to reach US$ 1,405.02 million by 2031; it is estimated to record a CAGR of 5.2% from 2023 to 2031.
Increasing Number of Patients in Emergency Units of Hospitals Fuels North America Blood Gas and Electrolyte Analyzer Market
The rising prevalence of diabetes, cancer, heart disease, and other chronic conditions propels the requirement for hospital emergency rooms (ER). Hospital emergency rooms offer vital medical care for patients affected by severe chronic conditions who need immediate attention and medical intervention. These services are complex, with each part being crucial to providing care. The primary objective of emergency medical services is immediately treating medical, surgical, and obstetric problems. The increasing number of patients seeking care in emergency hospital emergency units positively impacts the demand for blood gas and electrolyte analyzers. According to the World Health Organization (WHO), around 150 million patients visit hospital emergency rooms across the world annually. The US records about 139.8 million ER visits per year, according to data released by the CDC in 2023. In addition, there was a 7.4% rise in ED visits in California between 2011 and 2021. As emergency departments face mounting pressure to deliver rapid and accurate assessments of critically ill patients, timely diagnostic information on blood gas values, electrolyte levels, and acid-base balance becomes paramount. Blood gas and electrolyte analyzers provide on-the-spot diagnostic data for evaluating and managing patients affected by respiratory distress, metabolic abnormalities, or critical conditions. The ability of these analyzers to provide real-time insights into a patient's oxygenation status, acid-base equilibrium, and electrolyte levels is crucial for guiding resuscitative measures and optimizing clinical outcomes in emergency settings.
The growing demand for blood gas and electrolyte analyzers in emergency units drives advancements in technology, such as portable and point-of-care devices, that enable rapid testing at the patient's bedside. These compact analyzers enhance workflow efficiency and improve patient outcomes by facilitating prompt diagnosis and treatment initiation. As hospitals prioritize enhancing emergency care services to meet the needs of a rising patient population, the blood gas and electrolyte analyzers market is witnessing increased adoption of technologically advanced solutions tailored to the urgent and critical care setting.
North America Blood Gas and Electrolyte Analyzer Market Overview
The North America blood gas and electrolyte analyzer market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America blood gas and electrolyte analyzer market in 2023. The growth is driven by increasing public awareness regarding cardiovascular diseases and growing research and collaboration to explore innovative therapeutic applications in the blood gas and electrolyte analyzer market. The market for blood gas and electrolyte analyzer test kits in North America is projected to spur with the presence of various key players in the market. In addition, the adoption of medical devices in healthcare operations for improving quality and reducing costs augments the growth of the blood gas and electrolyte analyzer market in the region.
North America Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
North America Blood Gas and Electrolyte Analyzer Market Segmentation
The North America blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the North America blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the North America blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the North America blood gas and electrolyte analyzer market is segmented into the US, Canada, and Mexico. The US dominated the North America blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the North America blood gas and electrolyte analyzer market.